Antiplatelet Effects of Chelerythrine Chloride Isolated from Zanthoxylum Simulans
Overview
Biophysics
Affiliations
Chelerythrine chloride is an antiplatelet agent isolated from Zanthoxylum simulans. Aggregation and ATP release of washed rabbit platelets caused by ADP, arachidonic acid, PAF, collagen, ionophore A23187 and thrombin were inhibited by chelerythrine chloride. Less inhibition was observed in platelet-rich plasma. The thromboxane B2 formation of washed platelets caused by arachidonic acid, collagen, ionophore A23187 and thrombin was decreased by chelerythrine chloride. Phosphoinositides breakdown caused by collagen and PAF was completely inhibited by chelerythrine chloride, while that of thrombin was only partially suppressed. Chelerythrine chloride inhibited the intracellular calcium increase caused by arachidonic acid, PAF, collagen and thrombin in quin-2/AM-loaded platelets. The cyclic AMP level of washed platelets did not elevated by chelerythrine chloride. The antiplatelet effect of chelerythrine chloride was not dependent on the incubation time and the aggregability of platelets inhibited by chelerythrine chloride was easily recovered after sedimenting the platelets by centrifugation and then the platelet pellets were resuspended. Chelerythrine chloride did not cause any platelet lysis, since lactate dehydrogenase activity was not found in the supernatant. These data indicate that the inhibitory effect of chelerythrine chloride on rabbit platelet aggregation and release reaction is due to the inhibition on thromboxane formation and phosphoinositides breakdown.
Li G, Piao C, Wan P, Li S, Wei Y, Zhao G BMC Neurosci. 2022; 23(1):39.
PMID: 35754033 PMC: 9235104. DOI: 10.1186/s12868-022-00726-8.
Harlan B, Becker H, Woodward J, Riegel A Neuropsychopharmacology. 2018; 43(10):2064-2074.
PMID: 29946104 PMC: 6098046. DOI: 10.1038/s41386-018-0106-9.
Role of PKCepsilon in PGF2alpha-stimulated MMP-2 secretion from human ciliary muscle cells.
Husain S, Crosson C J Ocul Pharmacol Ther. 2008; 24(3):268-77.
PMID: 18462068 PMC: 2981373. DOI: 10.1089/jop.2008.0014.
Han R, Bakker A Br J Pharmacol. 2003; 138(3):417-26.
PMID: 12569066 PMC: 1573677. DOI: 10.1038/sj.bjp.0705035.
Effect of serine/threonine kinase inhibitors on motility of human lymphocytes and U937 cells.
Thorp K, Southern C, Matthews N Immunology. 1994; 81(4):546-50.
PMID: 8039806 PMC: 1422375.